References
- Baiano, C., Barone, P., Trojano, L., & Santangelo, G. (2020). Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis. Movement Disorders, 35(1), 45–54. https://doi.org/10.1002/mds.27902
- Cass, W. A., Smith, M. P., & Peters, L. E. (2006). Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Annals of the New York Academy of Sciences, 1074, 261–271. doi:https://doi.org/10.1196/annals.1369.023
- Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangpricha, V. (2008). Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of Neurology, 65(10), 1348–1352. doi:https://doi.org/10.1001/archneur.65.10.1348
- Evatt, M. L., DeLong, M. R., Kumari, M., Auinger, P., McDermott, M. P., & Tangpricha, V. (2011). High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Archives of Neurology, 68(3), 314–319. https://doi.org/10.1001/archneurol.2011.30
- Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005). Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. Journal of Chemical Neuroanatomy, 29(1), 21–30. doi:https://doi.org/10.1016/j.jchemneu.2004.08.006
- Fahn, S., & Elton, R. L. (1987). UPDRS program members Parkinson’s Disease Rating Scale. In S. Fahn, C. D. Marsden, M. Goldstein, & D. B. Calne (Eds.), Recent developments in Parkinson's disease (Vol. 2, pp. 153–163). Florham Park: Macmillanm Healthcare Information.
- Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51(6), 745–752. doi:https://doi.org/10.1136/jnnp.51.6.745
- Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357(3), 266–281. doi:https://doi.org/10.1056/NEJMra070553
- Kalueff, A. V., & Tuohimaa, P. (2007). Neurosteroid hormone vitamin D and its utility in clinical nutrition. Current Opinion in Clinical Nutrition and Metabolic Care, 10(1), 12–19. doi:https://doi.org/10.1097/MCO.0b013e328010ca18.
- Lau, H., Mat Ludin, A. F., Rajab, N. F., & Shahar, S. (2017). Identification of neuroprotective factors associated with successful ageing and risk of cognitive impairment among Malaysia older adults. Current Gerontology and Geriatrics Research, 2017, 1–7. https://doi.org/10.1155/2017/4218756
- Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., … Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : official Journal of the Movement Disorder Society, 27(3), 349–356. doi:https://doi.org/10.1002/mds.24893
- Masoumi, A., Goldenson, B., Ghirmai, S., Avagyan, H., Zaghi, J., Abel, K., … Fiala, M. (2009). 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. Journal of Alzheimer's Disease : JAD, 17(3), 703–717. doi:https://doi.org/10.3233/JAD-2009-1080
- McCleery, J., Abraham, R. P., Denton, D. A., Rutjes, A. W., Chong, L. Y., Al-Assaf, A. S., … Tabet, N. (2018). Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. The Cochrane Database of Systematic Reviews, 11(11), CD011905. https://doi.org/10.1002/14651858.CD011905.pub2
- McKenna, M. J., & Freaney, R. (1998). Secondary hyperparathyroidism in the elderly: Means to defining hypovitaminosis D. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa, 8 (Suppl 2), S3–S6. doi:https://doi.org/10.1007/pl00022725
- Moon, J. H., Lim, S., Han, J. W., Kim, K. M., Choi, S. H., Kim, K. W., & Jang, H. C. (2015). Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: The Korean Longitudinal Study on Health and Aging (KLoSHA). Clinical Endocrinology, 83(1), 36–42. https://doi.org/10.1111/cen.12733
- Morisco, F., Colao, A., Guarino, M., Lembo, V., Granata, R., Donnarumma, L., … Caporaso, N. (2013). Vitamin D levels and chronic hepatitis C. e-SPEN Journal, 8(4), e169–e174. doi:https://doi.org/10.1016/j.clnme.2013.04.006
- Newmark, H. L., & Newmark, J. (2007). Vitamin D and Parkinson's disease-a hypothesis. Movement Disorders : official Journal of the Movement Disorder Society, 22(4), 461–468. doi:https://doi.org/10.1002/mds.21317
- Nicoletti, A., Luca, A., Baschi, R., Cicero, C. E., Mostile, G., Davì, M., … Monastero, R. (2019). Incidence of mild cognitive impairment and dementia in Parkinson's Disease: The Parkinson's disease cognitive impairment study. Frontiers in Aging Neuroscience, 11, 21. doi:https://doi.org/10.3389/fnagi.2019.00021
- Ouma, S., Suenaga, M., Bölükbaşı Hatip, F. F., Hatip-Al-Khatib, I., Tsuboi, Y., & Matsunaga, Y. (2018). Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease. Brain and Behavior, 8(3), e00936. doi:https://doi.org/10.1002/brb3.936
- Pedersen, K. F., Larsen, J. P., Tysnes, O. B., & Alves, G. (2017). Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study. Neurology, 88(8), 767–774. https://doi.org/10.1212/WNL.0000000000003634
- Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194. doi:https://doi.org/10.1111/j.1365-2796.2004.01388.x
- Peterson, A. L., Mancini, M., & Horak, F. B. (2013). The relationship between balance control and vitamin D in Parkinson's disease-a pilot study. Movement Disorders : Official Journal of the Movement Disorder Society, 28(8), 1133–1137. doi:https://doi.org/10.1002/mds.25405
- Peterson, A. L., Murchison, C., Zabetian, C., Leverenz, J. B., Watson, G. S., Montine, T., … Quinn, J. F. (2013). Memory, mood, and vitamin D in persons with Parkinson's disease. Journal of Parkinson's Disease, 3(4), 547–555. https://doi.org/10.3233/JPD-130206
- Pigott, K., Rick, J., Xie, S. X., Hurtig, H., Chen-Plotkin, A., Duda, J. E., … Weintraub, D. (2015). Longitudinal study of normal cognition in Parkinson disease. Neurology, 85(15), 1276–1282. https://doi.org/10.1212/WNL.0000000000002001
- Santangelo, G., Vitale, C., Picillo, M., Moccia, M., Cuoco, S., Longo, K., … Barone, P. (2015). Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study. Parkinsonism & Related Disorders, 21(10), 1219–1226. doi:https://doi.org/10.1016/j.parkreldis.2015.08.024
- Sato, Y., Honda, Y., & Iwamoto, J. (2007). Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology, 68(12), 911–915.
- Schlögl, M., & Holick, M. F. (2014). Vitamin D and neurocognitive function. Clinical Interventions in Aging, 9, 559–568. https://doi.org/10.2147/CIA.S51785.
- Sleeman, I., Aspray, T., Lawson, R., Coleman, S., Duncan, G., Khoo, T. K., … Yarnall, A. (2017). The Role of Vitamin D in Disease Progression in Early Parkinson's Disease. Journal of Parkinson's Disease, 7(4), 669–675. https://doi.org/10.3233/JPD-171122
- Sommer, I., Griebler, U., Kien, C., Auer, S., Klerings, I., Hammer, R., … Gartlehner, G. (2017). Vitamin D deficiency as a risk factor for dementia: A systematic review and meta-analysis. BMC Geriatrics, 17(1), 16. doi:https://doi.org/10.1186/s12877-016-0405-0
- Sonnenberg, J., Luine, V. N., Krey, L. C., & Christakos, S. (1986). 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology, 118(4), 1433–1439. doi:https://doi.org/10.1210/endo-118-4-1433
- Thacher, T. D., & Clarke, B. L. (2011). Vitamin D insufficiency. Mayo Clinic Proceedings, 86(1), 50–60. doi:https://doi.org/10.4065/mcp.2010.0567
- Valenzuela, M. J., & Sachdev, P. (2006). Brain reserve and cognitive decline: A non-parametric systematic review. Psychological Medicine, 36(8), 1065–1073. https://doi.org/10.1017/S0033291706007744
- Wang, J., Yang, D., Yu, Y., Shao, G., & Wang, Q. (2016). Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease. Nutrients, 8(3), 142. https://doi.org/10.3390/nu8030142
- Zhao, Y., Sun, Y., Ji, H. F., & Shen, L. (2013). Vitamin D levels in Alzheimer's and Parkinson's diseases: A meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.), 29(6), 828–832. doi:https://doi.org/10.1016/j.nut.2012.11.018